Evaluation of a procoagulant phospholipid functional assay as a routine test for measuring circulating microparticle activity
Authors:
- Elena CampelloECElena Campello
- Luca SpieziaLSLuca Spiezia
- Claudia M. RaduCRClaudia M. Radu
- Sabrina GavassoSGSabrina Gavasso
- Barry WoodhamsBWBarry Woodhams
- Paolo SimioniPSPaolo Simioni
- 1 July 2014
- journal article
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 25 (5) , 534-537
Abstract
Microparticles are now considered as critical effectors involved in numerous biological processes (coagulation, inflammation, and vascular biology). Microparticle can be measured using a quantitative and descriptive approach by flow cytometry (FCT) or by a functional approach assessing microparticle biological activities by a factor Xa-based clotting assay. FCT can be used to determine the cellular origin of the different microparticles, although there are concerns about the detection limit of this approach. Functional assays measure only the procoagulant activity of isolated microparticles and give no information on the cellular source or the physical properties of the microparticles. The advantage of the functional assays is that the assays use well defined reagents, and they are readily automated with high sensitivity and simplicity. In this study, we analyzed samples from 60 patients with active cancer of different type, 60 patients with a BMI more than 25 kg/m, and 49 carriers of Factor V Leiden with and without a prior venous thromboembolic episode. The study showed a significant correlation (P < 0.05) between microparticles determined by annexin V-microparticle-based FCT and a procoagulant activity-based clotting assay. This indicates that the procoagulant assay could be used as a routine screening test to screen out the normal samples so that only the abnormal samples need further testing by FCT.Keywords
This publication has 16 references indexed in Scilit:
- Circulating microparticles: square the circleBMC Cell Biology, 2013
- Alternative Methods for Characterization of Extracellular VesiclesFrontiers in Physiology, 2012
- Microparticles in Hemostasis and ThrombosisCirculation Research, 2011
- Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolismThrombosis Research, 2011
- Zeta Potential Mediated Reaction Monitoring on Nano and MicroparticlesBioconjugate Chemistry, 2011
- Pre-analytical and analytical issues in the analysis of blood microparticlesThrombosis and Haemostasis, 2011
- Standardization of platelet‐derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshopJournal of Thrombosis and Haemostasis, 2010
- Membrane microparticles in VTE and cancerThrombosis Research, 2010
- Atomic force microscopy: a novel approach to the detection of nanosized blood microparticlesJournal of Thrombosis and Haemostasis, 2010
- Detection of the procoagulant activity of microparticle-associated phosphatidylserine using XACTBlood Coagulation & Fibrinolysis, 2009